{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:40:26Z","timestamp":1788867626616,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myelin oligodendrocyte glycoprotein immunoglobulin G associated optic neuritis (MOG-ON) is a recently described entity. Recent studies have shown that MOG-ON has a more severe clinical presentation than classic optic neuritis (ON).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to define morphological characteristics of MOG-ON, correlate these with clinical characteristics and compare them with multiple sclerosis associated ON (MS-ON) and healthy controls (CTRL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a retrospective study, we included MOG-ON and MS-ON patients seen between 2011 and 2018 at the University Hospital Bern. Data from clinical examination, perimetry, and optical coherence tomography (OCT) were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 66 eyes of 43 patients were included; 22 MS-ON and 33 CTRL eyes were sex- and age-matched to 11 MOG-ON eyes. We found significantly worse visual acuity at nadir, but better recovery and thinner global peripapillary retinal nerve fiber layer thickness in MOG-ON patients compared to MS-ON patients. Both groups exhibited irregular thinning of the macular ganglion cell layer. Furthermore, the visual acuity and visual field parameters correlated to retinal layer thickness only in MOG-ON eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In comparison to MS-ON, MOG-ON is associated with more prominent acute vision loss and more pronounced global thinning of the pRNFL. Both entities result in similar final visual acuity and atrophy of the macular ganglion cell layer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-020-10097-x","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T11:04:08Z","timestamp":1597230248000},"page":"276-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6284-5357","authenticated-orcid":false,"given":"Rino","family":"Vicini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-6652","authenticated-orcid":false,"given":"Dominik","family":"Br\u00fcgger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5150-9320","authenticated-orcid":false,"given":"Mathias","family":"Abegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4751-299X","authenticated-orcid":false,"given":"Anke","family":"Salmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-3752","authenticated-orcid":false,"given":"Hilary Michelle","family":"Grabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"10097_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/WCO.0000000000000766","volume":"33","author":"JJ Chen","year":"2020","unstructured":"Chen JJ, Bhatti MT (2020) Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Curr Opin Neurol 33:47\u201354. https:\/\/doi.org\/10.1097\/WCO.0000000000000766","journal-title":"Curr Opin Neurol"},{"key":"10097_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13:280. https:\/\/doi.org\/10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"10097_CR3","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR et al (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140:3128\u20133138. https:\/\/doi.org\/10.1093\/brain\/awx276","journal-title":"Brain"},{"key":"10097_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","volume":"195","author":"JJ Chen","year":"2018","unstructured":"Chen JJ, Flanagan EP, Jitprapaikulsan J et al (2018) Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol 195:8\u201315. https:\/\/doi.org\/10.1016\/j.ajo.2018.07.020","journal-title":"Am J Ophthalmol"},{"key":"10097_CR5","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1212\/WNL.0000000000008738","volume":"94","author":"F M\u00fchlemann","year":"2020","unstructured":"M\u00fchlemann F, Grabe H, Fok A et al (2020) Homonymous hemiatrophy of ganglion cell layer from retrochiasmal lesions in the visual pathway. Neurology 94:e323\u2013e329. https:\/\/doi.org\/10.1212\/WNL.0000000000008738","journal-title":"Neurology"},{"key":"10097_CR6","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.1212\/WNL.0000000000006873","volume":"92","author":"SC Xu","year":"2019","unstructured":"Xu SC, Kardon RH, Leavitt JA et al (2019) Optical coherence tomography is highly sensitive in detecting prior optic neuritis. Neurology 92:e527\u2013e535. https:\/\/doi.org\/10.1212\/WNL.0000000000006873","journal-title":"Neurology"},{"key":"10097_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00415-016-8333-7","volume":"264","author":"J Havla","year":"2017","unstructured":"Havla J, K\u00fcmpfel T, Schinner R et al (2017) Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. J Neurol 264:139\u2013151. https:\/\/doi.org\/10.1007\/s00415-016-8333-7","journal-title":"J Neurol"},{"key":"10097_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/1756285616655264","volume":"9","author":"EH Martinez-Lapiscina","year":"2016","unstructured":"Martinez-Lapiscina EH, Sepulveda M, Torres-Torres R et al (2016) Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders. Ther Adv Neurol Disord 9:436\u2013440. https:\/\/doi.org\/10.1177\/1756285616655264","journal-title":"Ther Adv Neurol Disord"},{"key":"10097_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519864928","author":"ES Sotirchos","year":"2019","unstructured":"Sotirchos ES, Filippatou A, Fitzgerald KC et al (2019) Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning. Mult Scler J. https:\/\/doi.org\/10.1177\/1352458519864928","journal-title":"Mult Scler J"},{"key":"10097_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/WNO.0000000000000669","volume":"39","author":"I Jelcic","year":"2019","unstructured":"Jelcic I, Hanson JV, Lukas S et al (2019) Unfavorable structural and functional outcomes in myelin oligodendrocyte glycoprotein antibody-associated optic neuritis. J Neuroophthalmol 39:3\u20137. https:\/\/doi.org\/10.1097\/WNO.0000000000000669","journal-title":"J Neuroophthalmol"},{"key":"10097_CR11","doi-asserted-by":"publisher","first-page":"e66151","DOI":"10.1371\/journal.pone.0066151","volume":"8","author":"E Schneider","year":"2013","unstructured":"Schneider E, Zimmermann H, Oberwahrenbrock T et al (2013) Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis. PLoS ONE 8:e66151. https:\/\/doi.org\/10.1371\/journal.pone.0066151","journal-title":"PLoS ONE"},{"key":"10097_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0256-1","author":"A-K Pr\u00f6bstel","year":"2015","unstructured":"Pr\u00f6bstel A-K, Rudolf G, Dornmair K et al (2015) Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-015-0256-1","journal-title":"J Neuroinflammation"},{"key":"10097_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","volume":"77","author":"AK Pr\u00f6bstel","year":"2011","unstructured":"Pr\u00f6bstel AK, Dornmair K, Bittner R et al (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77:580\u2013588. https:\/\/doi.org\/10.1212\/WNL.0b013e318228c0b1","journal-title":"Neurology"},{"key":"10097_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H et al (2006) Visual acuities \u201cHand Motion\u201d and \u201cCounting Fingers\u201d can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci 47:1236\u20131240. https:\/\/doi.org\/10.1167\/iovs.05-0981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10097_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1109\/TMI.2012.2225152","volume":"32","author":"PA Dufour","year":"2013","unstructured":"Dufour PA, Ceklic L, Abdillahi H et al (2013) Graph-based multi-surface segmentation of OCT data using trained hard and soft constraints. IEEE Trans Med Imaging 32:531\u2013543. https:\/\/doi.org\/10.1109\/TMI.2012.2225152","journal-title":"IEEE Trans Med Imaging"},{"key":"10097_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ophtha.2013.08.045","volume":"121","author":"M Abegg","year":"2014","unstructured":"Abegg M, Dysli M, Wolf S et al (2014) Microcystic macular edema: retrograde maculopathy caused by optic neuropathy. Ophthalmology 121:142\u2013149. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.045","journal-title":"Ophthalmology"},{"key":"10097_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/IJG.0000000000000633","volume":"26","author":"J Brazerol","year":"2017","unstructured":"Brazerol J, Iliev ME, H\u00f6hn R et al (2017) Retrograde maculopathy in patients with glaucoma. J Glaucoma 26:423\u2013429. https:\/\/doi.org\/10.1097\/IJG.0000000000000633","journal-title":"J Glaucoma"},{"key":"10097_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"10097_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.18240\/ijo.2020.01.17","volume":"13","author":"PW MacIntosh","year":"2020","unstructured":"MacIntosh PW, Kumar SV, Saravanan VR, Shah VM (2020) Acute changes in ganglion cell layer thickness in ischemic optic neuropathy compared to optic neuritis using optical coherence tomography. Int J Ophthalmol 13:120\u2013123. https:\/\/doi.org\/10.18240\/ijo.2020.01.17","journal-title":"Int J Ophthalmol"},{"key":"10097_CR20","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1167\/iovs.11-9300","volume":"53","author":"D Aggarwal","year":"2012","unstructured":"Aggarwal D, Tan O, Huang D, Sadun AA (2012) Patterns of ganglion cell complex and nerve fiber layer loss in nonarteritic ischemic optic neuropathy by fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:4539\u20134545. https:\/\/doi.org\/10.1167\/iovs.11-9300","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10097_CR21","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1212\/01.wnl.0000345042.53843.d5","volume":"72","author":"RT Naismith","year":"2009","unstructured":"Naismith RT, Tutlam NT, Xu J et al (2009) Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72:1077\u20131082. https:\/\/doi.org\/10.1212\/01.wnl.0000345042.53843.d5","journal-title":"Neurology"},{"key":"10097_CR22","doi-asserted-by":"publisher","first-page":"e0170847","DOI":"10.1371\/journal.pone.0170847","volume":"12","author":"H Stiebel-Kalish","year":"2017","unstructured":"Stiebel-Kalish H, Lotan I, Brody J et al (2017) Retinal nerve fiber layer may be better preserved in MOG-IgG versus AQP4-IgG optic neuritis: a cohort study. PLoS ONE 12:e0170847. https:\/\/doi.org\/10.1371\/journal.pone.0170847","journal-title":"PLoS ONE"},{"key":"10097_CR23","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00415-012-6466-x","volume":"259","author":"MA Seigo","year":"2012","unstructured":"Seigo MA, Sotirchos ES, Newsome S et al (2012) In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 259:2119\u20132130. https:\/\/doi.org\/10.1007\/s00415-012-6466-x","journal-title":"J Neurol"},{"key":"10097_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/WNO.0b013e318221b434","volume":"31","author":"EC Davies","year":"2011","unstructured":"Davies EC, Galetta KM, Sackel DJ et al (2011) Retinal ganglion cell layer volumetric assessment by spectral-domain oct in ms: application of a high precision manual estimation technique. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 31:260\u2013264. https:\/\/doi.org\/10.1097\/WNO.0b013e318221b434","journal-title":"J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc"},{"key":"10097_CR25","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","volume":"90","author":"A Cobo-Calvo","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E et al (2018) Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology 90:e1858\u2013e1869. https:\/\/doi.org\/10.1212\/WNL.0000000000005560","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10097-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10097-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10097-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T19:34:24Z","timestamp":1628710464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10097-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10097"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10097-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"R Vicini, D Br\u00fcgger, M Abegg and HM Grabe declare that they have no conflict of interest. A Salmen received speaker honoraria and\/or travel compensation for activities with Almirall Hermal GmbH, Biogen, Merck, Novartis, Roche and Sanofi Genzyme, and research support of the Swiss MS society not related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The manuscript does not contain clinical studies. This study was approved by the local cantonal ethics committee Bern under the project ID 2018-01151 and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}